HC Wainwright Reiterates Buy Rating for Krystal Biotech (NASDAQ:KRYS)
HC Wainwright reissued their buy rating on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a report released on Tuesday morning,Benzinga reports. The brokerage currently has a $240.00 price objective on the stock. Several other equities research analysts also recently issued reports on KRYS. Jefferies Financial Group began coverage on Krystal Biotech in a […]
HC Wainwright reissued their buy rating on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a report released on Tuesday morning,Benzinga reports. The brokerage currently has a $240.00 price objective on the stock. Several other equities research analysts also recently issued reports on KRYS. Jefferies Financial Group began coverage on Krystal Biotech in a […]
